Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: A prospective population-based study in 76 113 Austrian adults

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 10, 2008, Pages 1857-1865

  Strasak, Alexander M ^a   Kelleher, Cecily C ^b   Klenk, Jochen ^a,c   Brant, Larry J ^d   Ruttmann, Elfriede ^a   Rapp, Kilian ^c   Concin, Hans ^e   Diem, Günter ^e   Pfeiffer, Karl P ^a   Ulmer, Hanno ^a,e  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF ULM   (Germany)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

glutamyltransferase; Cardiovascular disease mortality; Epidemiology; Longitudinal change; Risk factor

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX RATIO; STROKE; AGE; AGED; AUSTRIA; BLOOD; ENZYMOLOGY; HEALTH SURVEY; LONGITUDINAL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TIME; UPREGULATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; UP-REGULATION;

EID: 53449096544     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.170597     Document Type: Article

References (45)

1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001; 38:263-355.
2. Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L, Pompella A, Paolicchi A. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001;22: 1802-1807.
3. Meister A. Metabolism and transport of glutathione and other gamma-glutamyl compounds. In: Larsson A, Orrenius S, Holmgren A, Mannervik B, editors. Functions of Glutathione: Biochemical, Toxicological and Clinical Aspects. New York: Raven Press: 1983. p. 1-22.
4. Rollason JG, Pincherle G, Robinson D. Serum gammaglutamyltranspeptidase in relation to alcohol consumption. Clin Chim Acta. 1972;39: 75-80.
5. Skinner HA, Holt S, Schuller R, Roy J, Israel Y. Identification of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med. 1984;101:847-851.
6. Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem. 2007;53:940-946.
7. Pompella A, Emdin M, Passino C, Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med. 2004;42:1085-1091.
8. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H; the Vorarlberg Health Monitoring and Promotion Program Study Group. γ-Glutamyltransferase as a risk factor for cardiovascular disease mortality. An epidemiological investigation in a cohort of 163 944 Austrian adults. Circulation. 2005;112:2130-2137.
9. Meisinger C, Döring A, Schneider A, Löwel H; KORA Study Group. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006; 189:297-302.
10. Hozawa A, Okamura T, Kadowaki T, Murakami Y, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Okayama A, Ueshima H; NIPPON DATA90 Research Group. Gamma-Glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis. 2007;194: 498-504.
11. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart diseases and all cause. Am J Epidemiol. 1995;142:699-708.
12. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self reported alcohol drinking, and the risk of stroke. Stroke. 2000;31:1851-1855.
13. Bots ML, Salonen JT, Elwood PC, Nikitin Y, Freire de Concalves A, Inzitari D, Sivenius J, Trichopoulou A, Tuomilehto J, Koudstaal PJ, Grobbee DE. Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project. J Epidemiol Community Health. 2002;56(suppl 1):25-29.
14. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr., Jousilahti P, Sundvall J, Tuomilehto J. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women. Eur Heart J. 2006;27:2170-2176.
15. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27: 127-133.
16. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248:230-238.
17. Lee DH, Ha MH, Kim JR, Gross M, Jacobs DR Jr. Gamma-glutamyltransferase, alcohol, and blood pressure. A four year follow-up study. Ann Epidemiol. 2002;12:90-96.
18. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr. Gamma-glutamyltransferase and diabetes - a 4 year follow-up study. Diabetologia. 2003;46:359-364.
19. Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, Boo Y, Steffen L, Jacobs DR Jr. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol. 2006;163:57-65.
20. Lee DH, Blomhoff R, Jacobs DR. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38:535-539.
21. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci. 2001;947:271-292.
22. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-85.
23. Ulmer H, Kelleher C, Diem G, Concin H. Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. Eur Heart J. 2003;24:1004-1013.
24. Nilssen O, Førde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: The Tromsø Study. Am J Epidemiol. 1994;139:787-792.
25. André P, Balkau B, Born C, Charles MA, Eschwège E; D.E.S.I.R. study group. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia. 2006;49:2599-2603.
26. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer KP, Ulmer H; the VHM&PP Study Group. Serum uric acid and risk of cardiovascular mortality: A prospective long-term study in 83 683 Austrian men. Clin Chem. 2008;54:273-284.
27. World Health Organization. International Classification of Diseases (ICD). http://www.who.int/classifications/icd/en.
28. Lissner L, Odell PM, D'Agostino RB, Stokes J III, Kreger BE, Belanger AJ, Brownell KD. Variability of body weight and health outcomes in the Framingham population. N Engl J Med. 1991;324:1839-1844.
29. Rapp K, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Schroeder J. Weight change and cancer risk in a cohort of more than 65 000 adults in Austria. Ann Oncol. 2008;19:641-648.
30. Golla A, Strauch K, Dietter J, Baur MP. Quantitative trait linkage analysis of longitudinal change in body weight. BMC Genet. 2003;4 Suppl 1:S7.
31. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
32. Feldman HA. Families of lines: random effects in linear regression analysis. J Appl Physiol. 1988;64:1721-1732.
33. Drøyvold WB, Lund Nilsen TI, Lydersen S, Midthjell K, Nilsson PM, Nilsson JA, Holmen J; the Nord-Trøndelag Health Study. Weight change and mortality: the Nord-Trøndelag Health Study. J Intern Med. 2005; 257:338-345.
34. Verbeke G, Lesaffre E. A linear mixed-effects model with heterogeneity in the random-effects population. J Am Stat Assoc. 1996;91:217-221.
35. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol. 1983; 117:165-172.
36. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997; 95:252-264.
37. Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y. Antithrombin-III and procoagulant activity - sex differences and effects of the menopause. Br J Haematol. 1990;74:77-81.
38. Ulmer H, Kelleher CC, Fitz-Simon N, Diem G, Concin H. Secular trends in cardiovascular risk factors: an age-period cohort analysis of 698,954 health examinations in 181,350 Austrian men and women. J Intern Med. 2007;261:566-576.
39. Hill DA. In vino veritas: alcohol and heart disease. Am J Med Sci. 2005;329:124-135.
40. De Oliveira E, Silva ER, Foster D, McGee Harper M, Seidman CE, Smith JD, Breslow JL, Brinton EA. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation. 2000;102:2347-2352.
41. Mukamal KJ, Jadhav PP, D'Agostino RB, Massaro JM, Mittleman MA, Lipinska I, Sutherland PA, Matheney T, Levy D, Wilson PW, Ellison RC, Silbershatz H, Muller JE, Tofler GH. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation. 2001;104:1367-1373.
42. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 1992;85:910-915.
43. Leppala JM, Paunio M, Virtamo J, Fogelholm R, Albanes D, Taylor PR, Heinonen OP. Alcohol consumption and stroke incidence in male smokers. Circulation. 1999;100:1209-1214.
44. Gronbaek M, Johansen D, Becker U, Hein HO, Schnohr P, Jensen G, Vestbo J, Sorensen TI. Changes in alcohol intake and mortality: a longitudinal population-based study. Epidemiology. 2004;15:222-228.
45. Ulmer H, Diem G, Bischof HP, Ruttmann E, Concin H. Recent trends and sociodemographic distribution of cardiovascular risk factors: results from two population surveys in the Austrian WHO CINDI demonstration area. Wien Klin Wochenschr. 2001;113:573-579.